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Mammalian ‘regulators of G protein signaling’ (RGS
proteins) help shut off G-protein-mediated signaling by
GTPase activation. But new evidence shows that RGS
proteins can also speed up the activation of signaling.
The combined effect is a change in signaling kinetics
without a decrease in signaling intensity.
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Cells must respond to a constantly changing stream of
chemical information. Neurotransmitters, hormones and
lipids are released and removed in complex patterns over
many different timescales. How G-protein signaling
converts this dynamic temporal information into appropri-
ate cellular responses depends on the kinetics of the
transduction process. Fast transduction kinetics allows
cells faithfully to follow agonist profiles and preserve tem-
poral information, whereas slower response kinetics can be
useful for filtering, integrating and mediating responses
over long timescales. 
Factors that control G-protein signaling kinetics should
profoundly influence cellular responses to dynamic
signals. A large family of mammalian ‘regulators of G
protein signaling’ (RGS proteins) have been cloned and
members of this family have been shown to attenuate
signal strength in some assays [1–3]. Recent studies of K+
channel activation and phototransduction suggest that
RGS proteins may also function as potent regulators of sig-
naling kinetics [4–6]. The surprise from these studies is
the finding that RGS proteins can change the nature of
the start and end of a signaling event, while leaving the
intensity of the signal unchanged.
RGS proteins are GAPs for heterotrimeric G proteins
Which steps in the G-protein cycle control the activation
and deactivation kinetics (Figure 1a)? Activation depends
on the rate at which ligand-bound receptor catalyzes
exchange of GDP for GTP on the Gα subunit. Following
exchange, GTP-bound Gα dissociates, at least partially,
from the receptor and Gβγ. The length of time that
GαGTP and Gβγ can interact with effectors is determined
by the rate at which Gα hydrolyzes GTP to GDP. Follow-
ing hydrolysis, inactive GαGDP binds Gβγ with high
affinity, and terminates Gβγ signaling. Intrinsic GTP
hydrolysis for purified Gα subunits is much slower
(~1–5 min–1) than the deactivation rates for some G-
protein-controlled processes, such as phototransduction
[6] and ion channel activation [7]. This suggests that
GTPase-activating proteins (GAPs), which speed up the
hydrolysis of GTP by Gα, must be present.
RGS proteins were first identified in screens for negative
regulators of yeast mating pheromone responses (Sst2) and
Caenorhabditis elegans egg-laying behavior (Egl-10) [8,9].
Sst2 and Egl-10 both contain a conserved RGS domain of
120 amino acids. A mammalian RGS protein, GAIP, was
independently cloned in a two-hybrid screen for Gαi-
interacting proteins [10]. Subsequently, over 15 mam-
malian genes have been identified that contain the
conserved RGS domain (Figure 2). In vitro biochemical
studies showed that RGS proteins have GAP activity for
Figure 1
Activity of RGS proteins. (a) Activation of GIRK channels: G-protein-
coupled receptors (GPCRs) bind ligand and catalyze nucleotide
exchange; free Gβγ then binds and activates GIRK channels.
Deactivation of GIRK channels: Gα hydrolyzes GTP — this step is faster
in the presence of RGS proteins — and GαGDP binds Gβγ, thereby
terminating GIRK activation. (b) GAP activity alone is predicted to speed
up deactivation rates and reduce the maximal signal amplitude (see trace
on right). The experiments of Doupnik et al. [4] and Saitoh et al. [5] show
that RGS proteins speed up both activation and deactivation rates
without decreasing the level of steady-state activation (see trace on left).
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purified Gαi and Gαq and can enhance GTP hydrolysis
rates as much as 100-fold [1,2,5,11–13]. 
RGS proteins bind to Gα–GDPAlF4–, a structural analog of
the GTPase transition state, much more tightly than they
bind either GαGTP or GαGTPγS, suggesting that they
speed up GTP hydrolysis by stabilizing the transition state.
The crystal structure of RGS4 complexed to
Gα–GDPAlF4– showed that the RGS domain folds into a
compact four-helix bundle, with its highly conserved
helix–loop residues contacting the Gα ‘switch’ regions [14].
The structure suggests that RGS proteins may decrease
activity, not only by acting as GAPs, but also by competi-
tively inhibiting effector binding to Gα switch regions.
Some degree of RGS specificity for different Gα proteins
has emerged from in vitro GAP assays and binding studies
(Figure 2). Most RGS proteins that have been tested
interact with Gαi and Gαo and exhibit GAP activity; only
RGS2 has been shown not to interact with Gαi or Gαo.
But specificity for Gαi subtypes has also been observed
[10]. The best GAPs for Gαq among the RGS proteins
tested are RGS2 and RGS4 [12,15]. Several RGS proteins
expressed in the retina accelerate GTP hydrolysis by
transducin, the trimeric G protein that transduces signal
from light-activated rhodopsin [16–18]. No RGS proteins
have yet been found to interact with Gαs. 
The lipid modification state of Gα at its amino terminus
can influence the efficacy and specificity of its RGS protein
interactions [19], although there is no contact between the
RGS domain of RGS4 and the amino terminus of Gαi1 in
the crystal structure [14]. This raises the possibility that
non-conserved parts of RGS proteins interact with Gα
outside the switch regions. The amino terminus of an RGS
protein is also likely to contain lipid-modification sites
and/or membrane-association domains [20]. A wide range of
interactions between RGS proteins, G proteins and the
membrane could confer specificity and target RGS proteins
to the Gαβγ complex or lipid microdomains.
It is not clear whether all RGS proteins are GAPs for Gαi,
Gαq or Gαt. The RGS domains in axin and D-AKAP are
less well conserved, and located at the amino terminus,
unlike the RGS domains of most mammalian RGS
proteins with known GAP activity [21,22]. Many of the
hydrophilic residues that contact Gαi and are required for
GAP activity [13] are not conserved in these proteins,
suggesting that they may have novel binding specificities
or functions. 
Kinetics of coupling to K+ channels
Many G-protein-coupled receptors in brain and heart
activate an inward rectifier K+ channel — known as GIRK
— through Gβγ (Figure 1a) [7]. GIRK channels rapidly
respond to G-protein signaling and provide a useful tool for
following G-protein kinetics. In atrial myocytes, full deacti-
vation of the GIRK current after removal of muscarinic
agonist occurs in less than a second, much faster than the
intrinsic GTP hydrolysis rate of Gαi. When the channels are
expressed in heterologous systems such as Xenopus oocytes
or tissue culture cells, GIRK currents deactivate slowly over
tens of seconds, a rate comparable to the intrinsic GTP
hydrolysis rate for Gαi. Co-expression of various RGS pro-
teins — RGS1, 3, 4 or 8 — with GIRK channels and recep-
tors in Xenopus oocytes has dramatic effects on deactivation
kinetics, speeding up recovery 3–6-fold (Figure 1b) [4,5].
This indicates that GTP hydrolysis, rather than intrinsic
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Figure 2
Summary of the domain structure, the
demonstrated Gα interactions, and known
tissue expression patterns of cloned RGS
proteins. Note that two different proteins have
been referred to as RGS9 [18,26], and that
the representations of RGS12, RGS14, axin
and D-AKAP2 are not drawn to scale.
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GIRK channel kinetics, determines the timecourse of
channel deactivation following agonist removal.
Unexpectedly, RGS co-expression was also found to
increase GIRK activation rates (Figure 1b) [4,5]. Indeed,
in mammalian cell lines, RGS4 was found to enhance both
activation and deactivation rates to levels similar to those
observed in heart and neurons [4]. Is this explained by
faster GTP hydrolysis? The time for activation to
approach equilibrium is inversely related to the sum of the
activation and deactivation rates, so increased GTPase
rates as a result of RGS overexpression could shorten the
time to reach equilibrium. Increasing the GTPase rate
should, however, reduce the GαGTP:GαGDP ratio at
equilibrium, reducing the maximal receptor-stimulated
GIRK current (Figure 1b). 
Neither group reported any negative effect of RGS on the
amplitude of GIRK activation [4,5]. Even when
nucleotide exchange rates are limited by low agonist con-
centrations, RGS still speeds up activation without reduc-
ing the steady-state GIRK current amplitude. It will be
important to reconcile this finding with other results
suggesting that RGS proteins greatly reduce the receptor
activation of other effectors, such as MAP kinase [3]. It
also will be important to determine if these results are
unique for G-protein activation of GIRK channels, or
whether RGS proteins regulate the kinetics of G-protein
coupling to other effectors, such as Ca2+ channels or phos-
phatidylinositol-3-kinase.
As RGS proteins speed up GIRK activation without
decreasing the steady-state current, they must directly
enhance an activation rate. How could RGS proteins
increase activation rates? The rate-limiting step for activa-
tion of GIRK channels is not known, so there are a
number of potential explanations. For example, RGS
proteins could directly promote the exchange of GTP for
bound GDP. Although no RGS protein has been shown to
bind with high affinity to GαGDP or speed up steady-
state nucleotide exchange of purified GαGDP, it has not
been tested whether RGS proteins speed up receptor-
catalyzed exchange through low-affinity interactions with
GαGDP or Gαβγ. Alternatively, RGS proteins could facil-
itate GαGTP dissociation from the receptor, or prevent
GαGTP reassociation, thereby enhancing potentially slow
binding or unbinding steps. 
There are other possibilities, for example RGS proteins may
promote the stability of a signaling complex with fast activa-
tion kinetics. Phospholipase C (PLC) is both an effector of
Gαq and a GAP for Gαq [23]. In a reconstituted system,
PLC greatly enhances the rate of receptor-catalyzed
GDP–GTP exchange. It has been suggested that this effect
results from formation of a stable complex between recep-
tor, G protein and PLC. Rapid GTP hydrolysis prevents the
G protein from fully dissociating from the receptor, allowing
the complex to avoid the slow step of G protein binding to
receptor. For such a model to account for GIRK activation,
it will be important to know if RGS proteins bind a recep-
tor–GαGTP complex, and whether GIRK activation
requires G protein dissociation from the receptor.
Lastly, RGS proteins could enhance Gβγ dissociation.
GIRK channels are activated by Gβγ rather than Gα, so
the effects of RGS proteins on GIRK activation must be
explained in terms of the lifetime of available Gβγ. This is
not straightforward, as it is not known whether Gβγ must
fully dissociate from Gα to activate GIRKs [24]. There is
evidence that GαGTP can still bind Gβγ, perhaps through
the α-helical amino terminus of Gα [25]. If complete dis-
sociation between GαGTP and Gβγ is required for effec-
tors to bind Gβγ, then RGS proteins may act as positive
regulators by forcing the dissociation of Gβγ from Gα and
thus increasing the level of free Gβγ available for interac-
tion with effectors. Such a pattern of binding will also
have implications for the attenuation of signaling by RGS
GAP activity: if RGS proteins act in this way, they should
inhibit Gα signaling to a greater extent than Gβγ
signaling. But RGS proteins potently inhibit G protein
activation of the mitogen activated protein (MAP) kinase
pathway [3] and the yeast mating response [8], both of
which require Gβγ. This is more consistent with RGS
simply accelerating GTP hydrolysis and thus the conver-
sion of Gα–GTP to Gα–GDP, which would compete with
effectors for binding to Gβγ.
Physiological functions of RGS proteins
Although our biochemical understanding of RGS proteins
has increased dramatically in recent years, we still know
very little about the physiological functions of mammalian
RGS proteins. Like their yeast and C. elegans counterparts,
mammalian RGS proteins could potentially function as
negative regulators of G-protein signaling. Because RGS
proteins can inhibit receptor activation of effectors such as
MAP kinases and PLC, mammalian RGS proteins could
antagonize long-lasting signals (with timescales in the
range minutes to hours) that control slow, and largely irre-
versible, cellular processes such as gene expression and
cytoskeletal rearrangement.
Cells in the brain, retina and heart must respond to signals
on a much faster timescale (milliseconds to seconds). As is
the case for GIRK activation and phototransduction, RGS
proteins may function less to reduce the magnitude of
responses than to tune signaling kinetics by accelerating
deactivation, and possibly also activation. By speeding up
deactivation, RGS proteins can reduce the total response
for short signals, and thereby greatly improve temporal res-
olution. For GIRKs, and possibly also other effectors, the
ability of RGS proteins to speed up activation may be
physiologically important. For example, rapid activation
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could be useful for generating robust cellular responses to
very short-lived signals, such as neurotransmitter released
from a single vesicle and quickly removed by diffusion,
reuptake or inactivation. In cases where RGS proteins only
have GAP activity, an abundance of receptors and G pro-
teins could ensure effector activation even in the presence
of RGS proteins. Thus, the primary effect of RGS proteins
would be to speed up activation and deactivation kinetics.
RGS proteins could influence many physiological
processes, so the regulation of RGS protein function
should be an exciting area of future research. Potential
mechanisms for regulating RGS proteins include lipid
modification, membrane association, post-translational
modification and interaction with other regulatory pro-
teins. The existence of many RGS proteins may allow
specific signals, even in the same cell, to be indepen-
dently controlled by regulating the expression of individ-
ual RGS proteins. Striking patterns of RGS mRNA in the
brain are consistent with highly regulated expression [26].
There are many scenarios in which we could imagine a
role for regulated RGS expression, such as development,
neuronal plasticity, desensitization, heart disease and
adaptation to chronic drug administration. G-protein path-
ways transduce some mitogenic signals, so it is interesting
to note that an RGS protein has been found to be up-regu-
lated by p53 [27,28], a tumor suppressor protein thought
in certain circumstances to put a brake on the cell cycle.
Immortal tissue-culture cells, on the other hand, appear to
have low levels of GAP activity. Down-regulation of RGS
proteins could be one way in which the power of mito-
genic signals is increased in cancer cells. 
At present, the analysis of mammalian RGS protein
function is limited to RGS overexpression experiments. A
better understanding of the normal physiological roles for
RGS proteins will require RGS gene ‘knockout’ mice and
the development of tools for inhibiting RGS function.
Such studies will help to determine the role(s) that RGS
proteins play in controlling the kinetics and magnitude of
G-protein signaling in different physiological contexts.
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